Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-13-000113

← back to feed
Filed
May 15, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q1 2013 · Mar 31, 2013 82.33M sh
Shares Diluted Q1 2013 · Mar 31, 2012 82.33M sh
Shares Outstanding Q1 2013 · Mar 31, 2013 82.33M sh
Operating Cash Flow Q1 2013 · Mar 31, 2013 −$6.01M
Operating Cash Flow Q1 2013 · Mar 31, 2012 −$84.29K
Long Term Debt Q1 2013 · Mar 31, 2013 $358.61K
Long Term Debt Q1 2013 · Dec 31, 2012 $346.42K
Sga Expense Q1 2013 · Mar 31, 2013 $2.61M
Sga Expense Q1 2013 · Mar 31, 2012 $15.59K
Rd Expense Q1 2013 · Mar 31, 2013 $1.3M
Net Income Q1 2013 · Mar 31, 2013 −$12.56M
Net Income Q1 2013 · Mar 31, 2012 −$35.7K
Current Liabilities Q1 2013 · Dec 31, 2012 $334.97K
Current Assets Q1 2013 · Dec 31, 2012 $9.4K
Total Assets Q1 2013 · Dec 31, 2012 $25.62K